Interferon alpha-2b biosimilar - Zydus Cadila
Alternative Names: IFNα-2b - Zydus CadilaLatest Information Update: 30 Oct 2021
Price :
$50 *
At a glance
- Originator Zydus Cadila
- Class Antineoplastics; Antivirals; Interferons; Recombinant proteins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Condylomata acuminata; Hepatitis B; Hepatitis C
Most Recent Events
- 28 Feb 2014 Launched for Condylomata acuminata in India (Intralesional)
- 28 Feb 2014 Launched for Hepatitis B in India (Parenteral)
- 28 Feb 2014 Launched for Hepatitis C in India (Parenteral)